Monday, April 29, 2019 11:44:50 PM
From CorMedix Website:
Presentation of Lock It 100 at the National Kidney Foundation in Boston May 10th 10:15am during their Late Breaking Research Presentation schedule.
Presenter looks to be a big deal.
Presenter: About Dr. Anil Agarwal, MD
Anil K Agarwal MD, FACP, FASN, FNKF, FASDIN
Professor of Medicine
Chief, Section of Nephrology at University Hospiital East
Director, Interventional Nephrology
Director of Clinical Scholarship for FAME
The Ohio State University Wexner Medical Center
Late-Breaking Research Presentations: The AWARD Trial and The LOCK-IT-100 Study Results
Friday, May 10, 2019 10:15 AM - 11:15 AM Room 312, Hynes Convention Center
Chair: Joseph Vassalotti, MD, FNKF
General CME/CE
Session Description
LOCK-IT-100: LOCK-IT-100, a multicenter, double-blind, active controlled trial randomized 805 hemodialysis (HD) patients using tunneled dialysis catheters at 70 US sites to compare Neutrolin® (an antimicrobial catheter lock solution containing taurolidine 1.35%, citrate 3.5%, & heparin 1000 U/mL) with heparin (1000 U/ml) for efficacy and safety in reducing catheter-related blood stream infections (CRBSIs) in HD patients. The trial was terminated early for efficacy by the Data Safety Monitoring Board, based on a 72% reduction in the risk of CRBSI by Neutrolin® compared to heparin, with no safety concerns identified. The LOCK-IT-100 trial demonstrated reduced risk of CRBSIs, a major cause of preventable hospitalizations, antibiotic use, healthcare costs, and excess mortality in HD.
Objectives
Discuss the results of LOCK-IT-100, a landmark randomized, controlled trial of an investigational catheter lock solution containing taurolidine, which demonstrated a statistically significant reduction in catheter-related bloodstream infections (CRBSIs) in patients on hemodialysis.
Program Tracks
Physician Program
Advanced Practitioner Program
CME/CE Credits/Contact Hours: 1
Presentations
Exercise and Physical Function in Older Adults with Advanced CKD: The AWARD Randomized Controlled Trial
10:15 AM - 10:40 AM
Speakers: Daniel Weiner, MD, MS, FNKF;Stephen Seliger, MD, MS
LOCK-IT-100: An Investigational Antimicrobial Catheter Lock Solution Shown to Reduce Life Threatening Infections in Hemodialysis Patients
10:40 AM - 11:05 AM
Speaker: Anil Agarwal, MD, FNKF
Question & Answer
11:05 AM - 11:15 AM
Speakers: Stephen Seliger, MD, MS;Anil Agarwal, MD, FNKF
Recent CRMD News
- CorMedix Inc. Receives FDA Feedback on Potential Label Expansion • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/23/2024 04:15:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:22:51 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/09/2024 09:06:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 12:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:40:17 AM
- CorMedix Inc. Announces CMS Grants TDAPA to DefenCath • GlobeNewswire Inc. • 04/19/2024 12:30:00 PM
- CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin) • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/12/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 10:26:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 01:11:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 01:10:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 01:09:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 01:04:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 01:39:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:05:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:11:33 PM
- CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:35:11 PM
- CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference • GlobeNewswire Inc. • 10/11/2023 12:30:00 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM